![](/wp-content/uploads/2022/10/October-12-2022-Blast-Cover.png)
$599
Sarissa Capital Challenges Amarin’s Management; Nemaura Receives Provisional Purchase Order from TPMENA
A series of cardiometabolic-related news items have been observed: Sarissa Capital Management LP announced plans to initiate the process of holding a special meeting of Amarin shareholders to reorganize the company’s Board; and Nemaura announced it received a provisional purchase order from its Middle East/North Africa licensee, TPMENA, for the non-invasive sugarBEAT CGM system. Below, FENIX provides highlights and insights for the respective new items.